Background
Methods
Patients
Samples used for microarrays (training set)
Variables | N (%) |
---|---|
Age (years) | |
Median (range) | 58.5 (37-83) |
Gender
| |
Male | 15 (62.5) |
Female | 9 (37.5) |
Tobacco use
| |
Yes | 16 (67) |
No | 8 (33) |
Alcohol use
| |
Yes | 17 (71) |
No | 7 (29) |
Tumor site
| |
Tongue | 16 (67) |
Floor of mouth | 4 (17) |
Buccal mucosa | 2 (8) |
Alveolar | 2 (8) |
T category
| |
T1-T2 | 12 (50) |
T3-T4 | 12 (50) |
Nodal status
| |
Negative (N0) | 12 (50) |
Positive (N1, N2b, N2c) | 12 (50) |
Tumor stage
| |
I, II | 7 (29) |
III, IV | 17 (71) |
Tumor grade
| |
Moderately differentiated | 18 (75) |
Poorly differentiated | 6 (25) |
Recurrence
| |
Yes | 9 (37.5) |
No | 15 (62.5) |
Time to recurrence
| |
Median (range) | 32 (1.8-34) |
Follow-up
| |
Median (range) | 13 (1.7-58.8) |
Outcome
| |
Alive with no evidence of disease | 13 (55) |
Alive with disease | 2 (8) |
Dead of disease | 7 (29) |
Dead of other causes | 2 (8) |
Samples used for quantitative real-time reverse-transcription PCR (RQ-PCR) (validation set)
Variables | N (%) |
---|---|
Age (years) | |
Median (range) | 67 (48-81) |
Gender
| |
Male | 21 (70) |
Female | 9 (30) |
Tobacco use
| |
Yes | 25 (83) |
No | 5 (17) |
Alcohol use
| |
Yes | 21 (70) |
No | 9 (30) |
Tumor site
| |
Tongue | 18 (50) |
Floor of mouth | 8 (27) |
Tongue + Floor of mouth | 3 (10) |
Buccal mucosa | 2 (7) |
Alveolar | 1 (3) |
Retromolar | 1 (3) |
T category
| |
T1-T2 | 14 (47) |
T3-T4 | 16 (53) |
Nodal status
| |
Negative (N0) | 24 (80) |
Positive (N1, N2b, N2c) | 6 (20) |
Tumor stage
| |
I, II | 13 (43) |
III, IV | 17 (57) |
Tumor grade
| |
Moderately differentiated | 23 (77) |
Poorly differentiated | 7 (23) |
Recurrence
| |
Yes | 7 (23) |
No | 23 (77) |
Time to recurrence
| |
Median (range) | 8 (2-36) |
Follow-up
| |
Median (range) | 21 (1-81) |
Outcome
| |
Alive with no evidence of disease | 23 (77) |
Alive with disease | 4 (13) |
Dead of disease | 2 (7) |
Dead of other causes | 1 (3) |
RNA Isolation, Microarrays and Validation Experiments
Bioinformatic Analyses
Meta-analysis of published microarray studies
Public Data Set Reference and Accession ID | Sample Size | Array Platform |
---|---|---|
Toruner et al. 2004
GDS1584
| 16 oral carcinoma and 4 adjacent normal tissues from 16 patients | Human Genome U133A Plus 2.0 (Affymetrix) |
Ye et al. 2008
GSE9844
| 26 oral carcinoma samples and 12 adjacent normal tissues from 26 patients | Human Genome U133A Plus 2.0 (Affymetrix) |
Kuriakose et al. 2004
GDS2520
| 22 head and neck carcinomas and 22 adjacent normal tissues from 22 patients | Human Genome U95A (Affymetrix) |
Sticht et al. 2008
GSE10121
| 35 oral carcinoma samples from 35 patients and 6 normal oral tissues from healthy individuals | Human Oligo Set 4.0 (Operon) |
Pyeon et al., 2007
GSE6791
| 42 head and neck carcinoma samples from 42 patients and 14 normal oral tissues from healthy individuals | Human Genome U133A Plus 2.0 (Affymetrix) |
Data analysis of in-house microarray study
Penalized Cox regression
Results
Patient characteristics: OSCC recurrence
Differentially expressed genes in margins, OSCC and normal oral tissues
Over-expressed genes in surgical margins: prognostic value for recurrence
Four-gene prognostic signature for OSCC recurrence
Gene | Coefficient | FC (microarray) | FC (RQ-PCR) |
p -value (qPCR) |
---|---|---|---|---|
MMP1
| 0.63 | 405 | 798 | 9E-16 |
COL4A1
| 0.25 | 3.7 | 4.3 | 7E-09 |
P4HA2
| 0.45 | 2.7 | 2.8 | 1E-06 |
THBS2
| 0.34 | 3 | 1.9 | 6E-03 |